Elly Ryu - 18 Feb 2022 Form 4 Insider Report for Sesen Bio, Inc. (CARM)

Role
Principal Accounting Officer
Signature
/s/ Mark R. Sullivan, as attorney-in-fact
Issuer symbol
CARM
Transactions as of
18 Feb 2022
Net transactions value
$0
Form type
4
Filing time
23 Feb 2022, 19:37:05 UTC
Previous filing
04 Oct 2021
Next filing
03 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CARM Common Stock Award $0 +86,300 $0.000000 86,300 18 Feb 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSUs") which shall vest annually in equal amounts over a four-year period following the grant date, so long as the reporting person remains employed by Sesen Bio, Inc.(the "Company"). Each RSU represents a contingent right to receive one share of the Company's common stock.